SUBSCRIBE
SUBSCRIBE
News   Deals

Sanofi Says Not Weighing Higher Aventis Bid

October 19, 2005 | 
1 min read

French drugmaker Sanofi Synthelabo (SASY.PA: Quote, Profile, Research) said on Tuesday it was not considering raising its bid for Franco-German rival Aventis (AVEP.PA: Quote, Profile, Research) at this stage.

Mergers & acquisitions Europe
Sanofi (France)
MORE ON THIS TOPIC
The EMA's former headquarters in London
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
March 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Creative background
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
February 28, 2025
 · 
2 min read
 · 
Annalee Armstrong
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
February 27, 2025
 · 
1 min read
 · 
Lori Ellis
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Editorial
The BioSpace Book Club Investigates the Biggest Deals of All Time
February 26, 2025
 · 
3 min read
 · 
Annalee Armstrong